|
|
CN
Online Message×
Click switch
Integrated Solutions

Deeply integrate R & D experience, constantly climb the peak of R & D technology, and build an integrated innovation service platform for new drug R & D.

Inhalation drug R & D platform
Medicilon is familiar with the development process and has extensive R&D experience of various inhalation formulations, especially in the field of DPI, nebulizer and nasal spray. The R&D are fully integrated with the requirements of domestic and foreign policies, regulations and guidelines.
Inhalation Formulation R&D Platform
Inhalation Toxicity Assessment
Relevant laboratories
Return